FDA 483 - ROVI Pharma Industrial Services S.A. - April 22, 2016

An FDA inspection of Rovi Contract Manufacturing S.L. in Madrid, Spain, revealed significant deficiencies in aseptic processing and quality control systems. The firm failed to adequately monitor environmental conditions, ensure the efficacy of disinfectants, and investigate unexplained discrepancies such as low production yields for sterile drug products.